MEAGAN FAZEKAS: Open Payments
NPI 1285215392 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 48 payments from 13 companies in 2025. Trend: 2023 $81 · 2024 $763 · 2025 $1,137
Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $197 |
| GENZYME CORPORATION | 13 | $194 |
| GlaxoSmithKline, LLC. | 5 | $194 |
| Verona Pharma, Inc. | 5 | $90 |
| INTUITIVE SURGICAL, INC. | 1 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Inspire Medical Systems, Inc. | 3 | $72 |
| Grifols USA, LLC | 2 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Viatris Specialty LLC | 2 | $49 |
Products named: DUPIXENT, NUCALA, Ohtuvayre, Da Vinci Surgical System, AIRSUPRA, INSPIRE, Prolastin-C Liquid, OFEV.
Industry payments across AL — which companies pay providers there.
